title: Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy.
abstract: We report a case of a 52-year-old woman presented with atypical central serous chorioretinopathy (CSCR) that had been misdiagnosed as posterior uveitis and treated with systemic corticosteroids and immunosuppressive therapy, with subsequent severe chorioretinal damage. Diagnosis was straightened through multimodal imaging. Anatomical improvement was achieved after discontinuation of corticosteroids and intravitreal injection of bevacizumab. However, visual acuity remained severely impaired in one eye. Failure to differentiate atypical CSCR from inflammatory chorioretinal diseases may lead to severe and irreversible visual impairment. Multimodal imaging helps recognition of the atypical presentations of CSCR, avoiding misdiagnosis and inappropriate management.
authors.affiliation: Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia.
authors.forename: Rim
authors.initials: R
authors.lastname: Kahloun
authors.affiliation: Department of Ophthalmology, Hedi Raies Institute of Ophthalmology, Tunis, Tunisia.
authors.forename: Amel
authors.initials: A
authors.lastname: Chebbi
authors.affiliation: Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia.
authors.forename: Sofiene Ben
authors.initials: SB
authors.lastname: Amor
authors.affiliation: Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia.
authors.forename: Imen
authors.initials: I
authors.lastname: Ksiaa
authors.affiliation: Department of Ophthalmology, Hedi Raies Institute of Ophthalmology, Tunis, Tunisia.
authors.forename: Leila
authors.initials: L
authors.lastname: Nacef
authors.affiliation: Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir, Monastir, Tunisia.
authors.forename: Moncef
authors.initials: M
authors.lastname: Khairallah
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D056833:Central Serous Chorioretinopathy / Q000175:diagnosis* / Q000188:drug therapy; D004396:Coloring Agents; D003937:Diagnosis, Differential; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D058449:Intravitreal Injections; D008875:Middle Aged; D064847:Multimodal Imaging; D041623:Tomography, Optical Coherence; D015866:Uveitis, Posterior / Q000175:diagnosis; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D004396:Coloring Agents; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D007208:Indocyanine Green
keywords: Central Serous Chorioretinopathy; Corticosteroids; Multimodal Imaging; Prognosis; Uveitis